Tilaknagar Industries Limited Approves Grant of 10,65,000 Stock Options Under Employee Scheme 2025
Tilaknagar Industries Limited has approved the grant of stock options to eligible employees under the Employees Stock Option Schemes 2025. The decision was made by the Nomination and Remuneration Committee (NRC) of the Board of Directors on August 15, 2026.The approval grants a total of 10,65,000 employee stock options (ESOPs). These options are granted in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Each option, when exercised, is convertible into one equity share of Tilaknagar Industries Limited. The shares have a face value of Rs. 10/- each.
The exercise price for the stock options has been set at Rs. 382 per Stock Option as granted.
Key Details of the Employee Stock Option Scheme 2025
The vesting period for these options commences from the date of grant, subject to a minimum tenure of one year. The structure details are provided below:| Metric | Detail |
|---|---|
| Total Options Granted | 10,65,000 ESOPs |
| Face Value per Share | Rs. 10/- (Rupees Ten only) |
| Exercise Price per Option | Rs. 382 (Rupees Three Hundred and Eighty-two only) |
| Minimum Vesting Period | 1 year from the grant date |
The vesting schedule for employees includes incremental milestones over five years:
| Milestone/Period | Percentage of Vesting |
|---|---|
| Completion of Second Year | 10% |
| Completion of Third Year | 20% |
| Completion of Fourth Year | 30% |
| Completion of Fifth Year | 40% |
The option grant terms stipulate that the Shares allotted upon exercise are not subject to any lock in period. The exercise period for options commences from the date of vesting and must be exercised within two years from the respective vesting period.
TI Stock Price Movement
On Friday, shares of Tilaknagar Industries Limited edged higher in a positive session, closing at ₹568.75 after gaining 3.10%. The stock achieved its 52-week high and closed on substantial volume as traded quantity reached 3.91 million.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.